British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Top Cited Papers
Open Access
- 17 April 2020
- Vol. 69 (6), 984-990
- https://doi.org/10.1136/gutjnl-2020-321244
Abstract
The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government’s advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.Keywords
This publication has 17 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurinesUnited European Gastroenterology Journal, 2019
- British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adultsGut, 2019
- IBD prevalence in Lothian, Scotland, derived by capture–recapture methodologyGut, 2019
- Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2017
- Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort StudyPLoS Medicine, 2016
- Primary care randomised controlled trial of a tailored interactive website for the self-management of respiratory infections (Internet Doctor)BMJ Open, 2016
- Ibuprofen, paracetamol, and steam for patients with respiratory tract infections in primary care: pragmatic randomised factorial trialBMJ, 2013
- A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel diseaseThe Esophagus, 2012
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ RegistryThe American Journal of Gastroenterology, 2012